Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoë Hunter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Canadian Family Physician Medecin De Famille Canadien|October 17, 2013
Facing the consequences of binge drinkingZoë Hunter, Louis Hugo Francescutti
Canadian Family Physician Medecin De Famille Canadien|March 16, 2017
Use of Facebook as part of a social media strategy for patient engagementClare Liddy, Zoë Hunter, Ariana Mihan, et al.
Scandinavian Journal of Pain|August 30, 2017
Patient perspectives on wait times and the impact on their life: A waiting room survey in a chronic pain clinicClare Liddy, Patricia A Poulin, Zoë Hunter, et al.
Blood Advances|March 17, 2026
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosisJohn O Mascarenhas, Laura Maria Fogliatto, Steven D Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction CancerJohn H Strickler, Judith Raimbourg, Jonathan E Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2026
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid TumorsManish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid TumorsManish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Canadian Family Physician Medecin De Famille Canadien|October 17, 2013
Facing the consequences of binge drinkingZoë Hunter, Louis Hugo Francescutti
Canadian Family Physician Medecin De Famille Canadien|March 16, 2017
Use of Facebook as part of a social media strategy for patient engagementClare Liddy, Zoë Hunter, Ariana Mihan, et al.
Scandinavian Journal of Pain|August 30, 2017
Patient perspectives on wait times and the impact on their life: A waiting room survey in a chronic pain clinicClare Liddy, Patricia A Poulin, Zoë Hunter, et al.
Blood Advances|March 17, 2026
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosisJohn O Mascarenhas, Laura Maria Fogliatto, Steven D Green, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction CancerJohn H Strickler, Judith Raimbourg, Jonathan E Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2026
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid TumorsManish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2026
Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid TumorsManish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
Pageof 1